Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4531306 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNAHSD17B10CHRM5 | |
| SCHEMBL4536563 | 0.89 | ALDH1A1 (0.38) | ALDH1A1TSHRLMNAHSD17B10CHRM5 | |
| SCHEMBL27538005 | 0.89 | — | — | |
| SCHEMBL11101894 | 0.89 | — | — | |
| SCHEMBL11113621 | 0.89 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNAHSD17B10CHRM5 | |
| SCHEMBL27675394 | 0.87 | — | — | |
| SCHEMBL28468659 | 0.87 | — | — | |
| SCHEMBL515761 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TSHRLMNAHSD17B10CHRM5 | |
| SCHEMBL515760 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TSHRLMNAHSD17B10CHRM5 | |
| SCHEMBL15034490 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TSHRLMNAHSD17B10CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090312344-A1 | ARYLPIPERAZINE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2009-12-17 | — | — | US | claimed |
| EP-1758583-A2 | ARYLPIPERAZINE DERIVATIVES USEFUL AS ADRENERGIC RECEPTOR ANTAGONISTS | Ranbaxy Laboratories Limited (IN) | 2007-03-07 | — | — | EP | claimed |
| WO-2006092710-A1 | METABOLITES OF 2-{3-[4-(2-ISOPROPOXYPHENYL) PIPERAZIN-1-YL]-PROPYL}-3A,4,7,7A-TETRAHYDRO-1H-ISOINDOLE-1,3-(2H)-DIONE | RANBAXY LABORATORIES LIMITED (IN) | 2006-09-08 | — | — | WO | claimed |
| WO-2005118537-A2 | ARYLPIPERAZINE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-12-15 | — | — | WO | claimed |
| EP-0122763-B1 | BLEACH COMPOSITIONS | Interox Chemicals Limited (GB) | 1987-06-16 | — | — | EP | claimed |
| EP-0092932-B1 | HYDROGEN PEROXIDE COMPOSITIONS | Interox Chemicals Limited (GB) | 1986-05-28 | — | — | EP | claimed |
| US-4545784-A | LOW-TEMPERATURE ACTIVATED BLEACHES; LAUNDERING; ANTISEPTICS; STORAGE STABILITY | INTEROX CHEMICALS LIMITED (GB) | 1985-10-08 | — | — | US | claimed |
| EP-0122763-A2 | Bleach compositions | Interox Chemicals Limited (GB) | 1984-10-24 | — | — | EP | claimed |
| EP-3997082-B1 | PROCESS FOR THE SYNTHESIS OF NON-RACEMIC CYCLOHEXENES | BASF CORP (US) | 2026-04-15 | — | — | EP | disclosed |
| CN-114174245-B | Synthesis method of non-racemized cyclohexene | 巴斯夫公司 | 2024-05-10 | — | — | CN | disclosed |
| US-11926589-B2 | Process for the synthesis of non-racemic cyclohexenes | BASF CORPORATION (US) | 2024-03-12 | — | — | US | disclosed |
| US-20220267247-A1 | PROCESS FOR THE SYNTHESIS OF NON-RACEMIC CYCLOHEXENES | BASF CORPORATION | 2022-08-25 | — | — | US | disclosed |
| EP-3997082-A1 | PROCESS FOR THE SYNTHESIS OF NON-RACEMIC CYCLOHEXENES | BASF CORPORATION (US) | 2022-05-18 | — | — | EP | disclosed |
| CN-114174245-A | Synthetic method of non-racemic cyclohexene | 巴斯夫公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-0092932-A1 | Hydrogen peroxide compositions | Interox Chemicals Limited (GB) | 1983-11-02 | — | — | EP | disclosed |
| EP-0078922-A1 | Process for the preparation of vitamins K3 and K4 and of their derivatives | BASF Aktiengesellschaft (DE) | 1983-05-18 | — | — | EP | disclosed |
| US-4176190-A | Diuretic and saliuretic sulphamoylbenzoic acids | CIBA-GEIGY CORPORATION (US) | 1979-11-27 | — | — | US | disclosed |
| US-4042707-A | ANALGESICS, NARCOTIC ANTAGONISTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| US-4016283-A | ADRENERGIC BLOCKING AGENTS | CIBA-GEIGY CORPORATION (US) | 1977-04-05 | — | — | US | disclosed |
| US-3984436-A | BLOCKERS OF ADRENERGIC B-RECEPTORS | CIBA-GEIGY CORPORATION (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267247-A1 | PROCESS FOR THE SYNTHESIS OF NON-RACEMIC CYCLOHEXENES | RPS10, ERAL1, DNER | ALDH1A1 3875/4885TSHR 24/4885LMNA 1675/4885 |
| US-11926589-B2 | Process for the synthesis of non-racemic cyclohexenes | RPS10, ERAL1, DNER | ALDH1A1 3875/4885TSHR 24/4885LMNA 1675/4885 |
| US-20090312344-A1 | ARYLPIPERAZINE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONISTS | ADRA1D, ADRB1, ADRA1A | ALDH1A1 50/4885TSHR 486/4885LMNA 2733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.